Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Confirm current GBP pricing on each live product page before raising a purchase order, as per-mg economics shift with promotional cycles
In 2019, the US FDA approved bremelanotide subcutaneous injection (Vyleesi, AMAG Pharmaceuticals) for the treatment of acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women making it only the second approved pharmacotherapy for female sexual dysfunction and the first melanocortin-based medicine to reach clinical approval
Free radicals that damage cellular lipids, proteins, and DNA
That last point matters
US$ 21.37
US$ 21.90
US$ 25.08
US$ 22.69
US$ 23.23
US$ 28.05
